NXTC
NextCure Inc
NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY
$9.21
+3.02% today
Updated 2026-04-30
Market cap
$34.70M
P/E ratio
—
P/S ratio
9.52x
EPS (TTM)
$-19.65
Dividend yield
—
52W range
$4 – $16
Volume
0.1M
NextCure Inc (NXTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-111.20%
ROA
-55.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-15.47M | — | — | — |
| 2018 | $0.00 | $-22.80M | — | — | — |
| 2019 | $6.35M | $-33.74M | -439.09% | -590.55% | -531.54% |
| 2020 | $22.38M | $-33.19M | 100.00% | -184.22% | -148.32% |
| 2021 | $0.00 | $-69.39M | — | — | — |
| 2022 | $0.00 | $-69.43M | — | — | — |
| 2023 | $0.00 | $-62.72M | — | — | — |
| 2024 | $0.00 | $-55.65M | — | — | — |
| 2025 | $0.00 | $-55.84M | — | — | — |